drugset / Trial / NCT00466999

Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion

NCT00466999

Completed 1000 enrolled Gynuity Health Projects
RandomizedSingle-groupOpen-labelTreatment

Summary

In this study, we will compare the safety and efficacy of 400 mcg sublingually administered misoprostol alone to standard surgical care for the treatment of incomplete abortion. This study will provide important data on the role of misoprostol in health services offering an array of treatments for incomplete abortion. Women could significantly benefit from a non-invasive treatment option for incomplete abortion. While safe surgical services are becoming more widespread, there is still a serious risk of complications from these procedures. Especially in developing countries, infection, hemorrhage and uterine damage are still too common. Medical treatment of incomplete abortion using misoprostol would be a tremendous step to reducing morbidity and mortality due to abortion complications.

Timeline

Start
2007-02
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 400 ug Other